LabRoots is pleased to announce the 3rd Annual Bioprocessing Virtual Event! Join us for this free, one-day event on April 7, 2021 as we discuss upstream and downstream processing, analytical development and quality, formulation and stability, cell and gene therapy production, and manufacturing.
This year's event includes the following topics:
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.
Like the 2020 conference, this event will be produced on our robust platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2021 BioProcessing Virtual Event. Submission is free. Submit your abstract here.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 35 credits.
Use #LRbioprocessing to follow the conversation!
Juergen Mairhofer co-founded enGenes Biotech after working as a Research Associate at the intersection of genetic and bioprocess engineering at the University of Natural Resources and Life Sciences (BOKU), Vienna, Austria. Prior to this, he held a PostDoc position at the Austrian Centre of Industrial Biotechnology (ACIB GmbH.), working in the research field “Microbial Cell Design”. He is inventor of the enGenes-X-press technology, a platform technology for cost-effective, growth-decoupled manufacturing of value-added products in Escherichia coli, author of several peer-reviewed publications, book chapters and patent applications. Juergen holds a Ph.D. in Biotechnology from the University of Natural Resources and Life Sciences, Vienna, Austria.
Patricia McNeill joined Lundbeck Seattle BioPharmaceuticals Inc. in October 2019 as part of the acquisition of Alder Biopharmaceuticals. As Associate Director of Cell Culture Development, she has overseen the successful upstream process development for early to late stage cell culture and fermentation processes producing therapeutic monoclonal antibodies. She was hired as the 10th employee at Alder and has since held progressive leadership roles including the build-out and expansion of the research development lab for yeast fermentation. As Alder grew and new production platforms were needed, Patricia was tasked in establishing a CHO cell culture platform from the ground up. Prior to Alder, Patricia worked at Corixa Corporation where she was responsible for production of E. coli antigens used in cancer vaccine therapies. Her passion is using Design of Experiment (DOE) studies to decrease Cost of Goods (COGs), increase process efficiency, and robustness, and speed up development timelines.
I am a 5th year PhD candidate in the Bioinformatics & Systems Biology program at UC San Diego with Dr. Nathan Lewis as my advisor. I received a B.S in Biology with a minor in computational neuroscience at Carnegie Mellon University, working on mu-opioid receptor recycling in Dr. Manoj Puthenveedu's lab. I then worked in Dr. Eric Halgren's lab, using ECog data to understand spatiotemporal patterns in sleep and memory. In the Lewis lab, my dissertation examines different points in the lifecycle of biopharmaceuticals, from production to application, using next-generation sequencing technology. My first project-the topic of my talk today- improves the resolution of the transcription start sites (TSSs) in the Chinese Hamster using comprehensive multi-omics across various tissues. This elucidated regulatory regions such as the TATA box and initiator element, enabled CRISPR activation for the Mgat3 gene, and provided a valuable resource for the CHO community. My second focus is on the application of a novel immuno-therapeutic to the clonal makeup of the hematopoietic CD34+ stem and progenitor cell population. Using a recently published single-cell mitochondrial ATAC-seq methodology for lineage tracing, we tracked clonal population expansions and regressions. I am very interested in genetic engineering in combination with sequencing and modeling techniques, and hope to incorporate these techniques to developing and understanding novel therapeutics.
Christian Witz has studied chemical process engineering. In his Ph.D. Witz created a novel simulation program for aerated and stirred bioreactors. He was recently named as a fellow in the Spin-Off Fellowship program of the Austrian Research Promotion Agency.
David Wood is a Professor of Chemical and Biomolecular Engineering at The Ohio State University. He received his undergraduate degree from Caltech in 1990 with a double major in Chemical Engineering and Molecular Biology, and then worked on Neupogen® manufacturing at Amgen and downstream process development at Bristol Myers Squibb. Since receiving his PhD from Rensselaer Polytechnic Institute over 20 years ago, professor Wood has developed groundbreaking new technologies in downstream bioprocessing with a focus on self-cleaving affinity tag methods. His work has led to several issued patents in this area, and he is now a co-founder of Protein Capture Science, a startup company commercializing his self-cleaving affinity tag technology.
Astrea Bioseparations Ltd (formerly Prometic Bioseparations Ltd) has long been established as an expert in affinity chromatography and bioseparations. Providing services for ligand design, adsorbent development, large scale adsorbent manufacture (up to 1,000L batch sizes) to GMP ...See more See less
For more than 30 years, GoldBio has been committed to researchers around the world. We know providing quality reagents to scientists leads to discoveries that benefit all. That is why we provide our customers with only the best chemicals, tested in GoldBio labs to ensure the ...See more See less
As a global leader in healthcare, Roche Diagnostics offers a broad portfolio of tools that help healthcare providers in the early detection, prevention, diagnosis and treatment of diseases. In Molecular Diagnostics, we are driven by a vision of working with laboratories like ...See more See less
PENTAPHARM has a long-standing tradition as an innovative and reliable supplier of active ingredients for the pharmaceutical, diagnostic and cosmetic industry. Our roots as researchers, developers and manufacturers of state-of-the-art products reach back to 1948. PENTAPHARM ...See more See less
POSTER SUBMISSION GUIDELINES
Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.
SUBMIT YOUR ABSTRACT
Enter the following information to this Submission Form:
If you are interested in sponsoring a Poster for this virtual event and generate leads, the cost is $250 and you can submit the poster at firstname.lastname@example.org.
All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.
If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.
Questions? Email Posters@LabRoots.com
The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
Nagarjun is a Scientist in Technical Operations at Sana Biotechnology (Cambridge, MA). He completed his PhD in Medical Sciences at Texas A&M University (Texas), where he worked on development of a universal lentiviral vector platform for different gene therapy applications. After ...See more See less
With more than 10 years of experience, Mark is a passionate expert in the field of biopharmaceutical process development. He worked together with several Top25 Pharma companies in different projects targeting their needs in process development and understanding. Together with his ...See more See less
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|
- For viewing Webinars:
- For viewing Virtual Events
Research And Development
LabRoots Registration (Also interested in)43%
WAVE Newsletter Promotion3%
Social Media Promotions1%
Medical Laboratory Technician7%
Clinical Laboratory Scientist2%
Life Science Company2%
Manufacturer & Biotech/pharma1%
Manufacturer - Other1%